Explore the feasibility of using spot‐scanning proton arc therapy for a synchrotron accelerator‐based proton therapy system – A simulation study
Journal of Applied Clinical Medical Physics · 2025
DOI: 10.1002/acm2.14526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Xiaoda Cong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Corewell Health William Beaumont Hospital, Royal Oak, Michigan, USA. Hauptthemen laut MEDLINE: Proton Therapy, Synchrotrons, Radiotherapy Planning, Computer-Assisted, Radiotherapy Dosage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective The aim of this study was to evaluate the feasibility and plan quality of spot‐scanning proton arc therapy (SPArc) using a synchrotron‐accelerator‐based proton therapy system compared to intensity‐modulated proton therapy (IMPT). Approach Five representative disease sites, including head and neck, lung, liver, brain chordoma, and prostate cancers, were retrospectively selected. Both IMPT and SPArc plans are generated with the HITACHI ProBEAT PBS system's minimum MU constraints and physics beam model. The SPArc plans are generated with 2.5° sampling frequency. The static delivery time was simulated based on the previously published synchrotron delivery sequence model, and the dynamic delivery time was simulated using a proton arc gantry mechanical model integrated with the synchrotron delivery sequence. Both dosimetric plan quality and delivery efficiency are evaluated. Main results A superior plan quality is reached compared with the IMPT plans generated for the same disease site. However, a relatively prolonged static and dynamic delivery time post new challenge, as static time increased by 49.22% and dynamic time 59.10% on average. Significance This study presents the first simulation results of delivering the SPArc plans using a synchrotron‐accelerated proton therapy system. The result shows its feasibility and limitations, which could guide future development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Corewell Health William Beaumont Hospital, Royal Oak, Michigan, USA.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Radiation Oncology, Stanford University, California, USA.
- Department of Radiation Oncology, Mayo Clinic, Arizona, USA.
ORCID-Profile: Jiajian Shen
Zitieren
APA
Cong, X., Liu, G., Liu, P., Zhao, L., Chen, S., Li, X., Shen, J., & Ding, X. (2025). Explore the feasibility of using spot‐scanning proton arc therapy for a synchrotron accelerator‐based proton therapy system – A simulation study. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14526
Vancouver
Cong X, Liu G, Liu P, Zhao L, Chen S, Li X, et al. Explore the feasibility of using spot‐scanning proton arc therapy for a synchrotron accelerator‐based proton therapy system – A simulation study. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.14526
BibTeX
@article{Cong2025,
author = {Cong, Xiaoda and Liu, Gang and Liu, Peilin and Zhao, Lewei and Chen, Shupeng and Li, Xiaoqiang and Shen, Jiajian and Ding, Xuanfeng},
title = {Explore the feasibility of using spot‐scanning proton arc therapy for a synchrotron accelerator‐based proton therapy system – A simulation study},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
doi = {10.1002/acm2.14526}
}
EUVIMED